The Harten Group - Latest Success Puts Harten Group on Cloud Nine 

July 21st 2003. The Harten Group, Europe’s leading interim management specialist for the life sciences sector, reached new heights recently when it recruited its 1,000th consultant and celebrated with a victory flight over Cambridgeshire.

MD, Vernon Harten Ash, took the latest and 1,000th consultant to join the Company, Flemming Jensen, on the celebration flight. Flemming has worked as CEO and at Board level with some of Europe’s leading pharmaceutical companies, most recently carrying out these roles at Lundbeck and latterly at Medicult.

Vernon Harten Ash said: “We have been providing support to senior management in biotech and pharmaceutical companies since 1994. Gaining our 1,000th consultant places us firmly in pole position, offering companies the largest bank of high value skills and expertise.

“The market for interim managers is growing rapidly, with senior executives seeing the advantages of using specialist skills at key stages in their business development. Our consultants are selected on their ability to grasp issues immediately and hit the ground running.”

Harten Group services include technical consulting, project management, provision of experienced interim managers, permanent recruitment and strategic planning. Recent clients include: AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme, Wyeth, Powderject, 3i, Cambridge Gateway Fund,

Johnson & Johnson, Adprotech and Cambridge Biotechnology.

Further information about The Harten Group can be found on www.hartengroup.co.uk which contains an innovative search capability enabling clients to look for potential executive interim managers within the company’s network of 1000 consultants. This feature is unique among life science industry providers and is routinely used by clients to identify matches with their skills needs.

ends